Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 62, Issue 1, 2000, Pages 13-19

  Xi, S ^a   Pham, H ^a   Ziboh, V A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; CORIOLIC ACID; TRANSCRIPTION FACTOR AP 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GUINEA PIG; MALE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTO ONCOGENE;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0034027026     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1999.0119     Document Type: Article

References (39)

1. Ziboh V. A. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids. 32:1994;S249-S253.
2. Miller C. C., McCreedy C. A., Jones A. D., Ziboh V. A. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products. Prostaglandins. 35:1988;917-938.
3. Miller C. C., Ziboh V. A. Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE). J Invest Dermatol. 94:1990;353-358.
4. Cho Y., Ziboh V. A. Incorporation of 13-hydroxyoctadecadienoic acid (13-HODE) into epidermal ceramide and phospholipids: phospholipase C-catalyzed release of novel 13-HODE-containing diacylglycerol. J Lipid Res. 35:1994;255-262.
5. Ziboh V. A., Yun M., Hyde D. M., Giri S. N. γ-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters. Lipids. 32:1997;759-767.
6. Mani I., Iversen L., Ziboh V. A. Upregulation of nuclear PKC and MAP-kinase during hyperproliferation of guinea pig epidermis: modulation by 13-hydroxyoctadecadienoic acid (13-HODE). Cell Signal. 10:1998;143-149.
7. Cho Y., Ziboh V. A. 13-hydroxyoctadecadienoic acid reverses epidermal hyperproliferation via selective inhibition of PKC-β activity. Biochem Biophys Res Comm. 201:1994;257-265.
8. Fisher C., Byers M. R., Iadarola M. J., Powers E. A. Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development. 111:1991;253-258.
9. Smeyne R. J., Schilling K., Robertson L., Luk D., Oberdick J., Curran T., Morgan J. I. fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron. 8:1992;13-23.
10. Briata P., D'Anna F., Franzi A. T., Gherzi R. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding. Exp Cell Res. 204:1993;136-146.
11. Domann F. E., Levy J. P., Finch J. S., Bowden G. T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog. 9:1994;61-66.
12. Grigoriadis A. E., Wang Z. Q., Wagner E. F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 11:1995;436-441.
13. Saez E., Rutberg S. E., Mueller E., Oppenheim H., Smoluk J., Yuspa S. H., Spiegelman B. M. C-fos is required for malignant progression of skin tumors. Cell. 82:1995;721-732.
14. Schuh A. C., Keating S. J., Monteclaro F. S., Vogt P. K., Breitman M. L. Obligatory wounding requirement for tumorigenesis in vjun transgeneic mice. Nature. 346:1990;756-760.
15. Hilberg F., Wagner E. F. Embryonic stem (ES) cells lacking functional c-jun: consequence for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene. 7:1992;2371-2380.
16. Smeyne R. J., Vendrell M., Hayward M. Continuous c-fos expression preceedes programmaed cell death in vivo. Nature. 363:1993;166-169.
17. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP-kinase on apoptosis. Science. 270:1995;1326-1331.
18. Schreiber M., Baumann B., Cotton M., Angel P., Wagner E. F. Fos is an essential component of the mammalian UV response. EMBO J. 14:1995;5338-5349.
19. Haas S., Kaina B. c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis. 16:1995;985-991.
20. Basset-Seguin N., Escot C., Moles J. P., Blanchard J. M., Kerai C., Guilhou J. J. C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Invest Dermatol. 97:1991;672-678.
21. Basset-Seguin N., Escot C., Blanchard J. M., Kerai C., Verrier B., Moin H., Guilhou J. J. High levels of c-fos proto-oncogene expression in normal human adult skin. J Invest Dermatol. 94:1990;418-422.
22. Standke G. J., Meier V. S., Croner B. Mammary gland factor activated by prolactin on mammary epithelial cells and acute phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential. Mol Endo. 8:1994;469-477.
23. Dignam J. D., Martin P. L., Shastry B. S., Roeder R. G. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:1983;582-598.
24. Eckert R. L., Welter J. F. Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Reports. 23:1996;59-70.
25. Welter J. F., Eckert R. L. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene. 11:1995;2681-2687.
26. Dong Z., Birrer M. J., Watts R. G., Matrisian L. M., Colburn N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Pro Natl Acad Sci USA. 91:1994;609-613.
27. Schlingensiepen K. H., Schlingensiepen R., Kunst M., Klinger I., Gerdes W., Seifert W., Brysch W. Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation. Dev Genet. 14:1993;305-312.
28. Rossi A., Jang S. I., Ceci R., Steinert P. M., Markova N. G. Effect of AP-1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes. J Invest Dermatol. 110:1998;34-40.
29. Berra E., Díaz-Meco M. T., Lozano J. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J. 14:1995;6157-6163.
30. Efimova T., LaCelle P., Welter J. F., Eckert R. L. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway. J Biol Chem. 273:1998;24387-24395.
31. Schütze S., Machleidt T., Krönke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leuko Biology. 56:1994;533-541.
32. Monick M. M., Carter A. B., Gudmundsson G., Geist L. J., Hunninghake G. W. Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes. Am J Physiol. 275:1998;L389L397.
33. Keogh B. P., Tresini M., Cristofalo V. J., Allen R. G. Effects of cellular aging on the induction of c-fos by antioxidant treatments. Mech Aging and Develop. 86:1996;151-160.
34. Zohn I. E., Yu H., Li X., Cox A. D., Earp H. S. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol. 15:1995;6160-6168.
35. Sassone-Corsi P., Sisson J. C., Vermal I. M. Transcriptional autoregulation of the proto-oncogene fos. Nature. 334:1988;314-319.
36. Boyle W. J., Smeal T., Defize L. H., Angel P., Woodgett J. R., Karin M., Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 64:1991;573-584.
37. de Groot R. P., Auwerx J., Bourouis M., Sassone-Corsi P. Negative regulation of Jun/AP-1: conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy. Oncogene. 8:1993;841-847.
38. Nikolakaki E., Coffer P. J., Hemelsoet R., Woodgett J. R., Defize L. H. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene. 8:1993;833-840.
39. Cho Y., Ziboh V. A. A novel 15-hydroxyeicosatrienoic acid- substituted diacylglycerol (15-HETrE-DAG) selectively inhibits epidermal protein kinase C-β Biochim Biophysica Acta. 1349:1997;67-71.